Cargando…
Anti-inflammatory activity of ivermectin in late-stage COVID-19 may reflect activation of systemic glycine receptors
Autores principales: | DiNicolantonio, James J, Barroso-Aranda, Jorge, McCarty, Mark F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057070/ https://www.ncbi.nlm.nih.gov/pubmed/33875563 http://dx.doi.org/10.1136/openhrt-2021-001655 |
Ejemplares similares
-
Ivermectin may be a clinically useful anti-inflammatory agent for late-stage COVID-19
por: DiNicolantonio, James J, et al.
Publicado: (2020) -
The cardiometabolic benefits of glycine: Is glycine an ‘antidote’ to dietary fructose?
por: McCarty, Mark F, et al.
Publicado: (2014) -
Melatonin may decrease risk for and aid treatment of COVID-19 and other RNA viral infections
por: DiNicolantonio, James J, et al.
Publicado: (2021) -
Thrombotic complications of COVID-19 may reflect an upregulation of endothelial tissue factor expression that is contingent on activation of endosomal NADPH oxidase
por: DiNicolantonio, James J, et al.
Publicado: (2020) -
Azithromycin and glucosamine may amplify the type 1 interferon response to RNA viruses in a complementary fashion
por: DiNicolantonio, James J., et al.
Publicado: (2020)